Clinical Trial Update: Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating mitoxantrone for venetoclax-resistant acute myeloid leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Leukemia, Myeloid Leukemia | Phase 1 | Status: RECRUITING